rs908806258
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 3P and 3B. PM2PP2BP4_ModerateBP6
The NM_003072.5(SMARCA4):āc.4905A>Cā(p.Gln1635His) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000143 in 1,398,584 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_003072.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SMARCA4 | ENST00000646693.2 | c.5001A>C | p.Gln1667His | missense_variant | 35/36 | NM_001387283.1 | ENSP00000495368.1 | |||
SMARCA4 | ENST00000344626.10 | c.4905A>C | p.Gln1635His | missense_variant | 34/35 | 1 | NM_003072.5 | ENSP00000343896.4 | ||
SMARCA4 | ENST00000643549.1 | c.4911A>C | p.Gln1637His | missense_variant | 34/35 | ENSP00000493975.1 | ||||
SMARCA4 | ENST00000541122.6 | c.4815A>C | p.Gln1605His | missense_variant | 34/35 | 5 | ENSP00000445036.2 | |||
SMARCA4 | ENST00000643296.1 | c.4815A>C | p.Gln1605His | missense_variant | 33/34 | ENSP00000496635.1 | ||||
SMARCA4 | ENST00000644737.1 | c.4815A>C | p.Gln1605His | missense_variant | 33/34 | ENSP00000495548.1 | ||||
SMARCA4 | ENST00000589677.5 | c.4812A>C | p.Gln1604His | missense_variant | 34/35 | 5 | ENSP00000464778.1 | |||
SMARCA4 | ENST00000643995.1 | c.4326A>C | p.Gln1442His | missense_variant | 31/32 | ENSP00000496004.1 | ||||
SMARCA4 | ENST00000644963.1 | c.3555A>C | p.Gln1185His | missense_variant | 27/28 | ENSP00000495599.1 | ||||
SMARCA4 | ENST00000644065.1 | c.3537A>C | p.Gln1179His | missense_variant | 26/27 | ENSP00000493615.1 | ||||
SMARCA4 | ENST00000642350.1 | c.3399A>C | p.Gln1133His | missense_variant | 26/27 | ENSP00000495355.1 | ||||
SMARCA4 | ENST00000643857.1 | c.3165A>C | p.Gln1055His | missense_variant | 24/25 | ENSP00000494159.1 | ||||
SMARCA4 | ENST00000538456.4 | c.969A>C | p.Gln323His | missense_variant | 7/8 | 3 | ENSP00000495197.1 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome AF: 0.00000143 AC: 2AN: 1398584Hom.: 0 Cov.: 33 AF XY: 0.00000145 AC XY: 1AN XY: 689822
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
Intellectual disability, autosomal dominant 16 Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Jul 15, 2021 | - - |
Rhabdoid tumor predisposition syndrome 2 Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Sep 05, 2023 | This sequence change replaces glutamine, which is neutral and polar, with histidine, which is basic and polar, at codon 1667 of the SMARCA4 protein (p.Gln1667His). This variant is not present in population databases (gnomAD no frequency). This variant has not been reported in the literature in individuals affected with SMARCA4-related conditions. ClinVar contains an entry for this variant (Variation ID: 484885). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) has been performed at Invitae for this missense variant, however the output from this modeling did not meet the statistical confidence thresholds required to predict the impact of this variant on SMARCA4 protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Hereditary cancer-predisposing syndrome Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 01, 2024 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at